Results 21 to 30 of about 41,093 (226)

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors

Frontiers in Oncology, 2019
Background: Significantly better local control is achieved with combination of whole brain radiotherapy and stereotactic radiosurgery in the treatment of multiple brain metastases.
Muhammad Khan, Muhammad Khan, Jie Lin, Guixiang Liao, Yunhong Tian, Yingying Liang, Rong Li, Mengzhong Liu, Mengzhong Liu, Yawei Yuan   +9 more
doaj   +1 more source

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial

BMC Cancer, 2023
Background The brain is a common site for cancer metastases. In case of large and/or symptomatic brain metastases, neurosurgical resection is performed.
Maria Waltenberger, Denise Bernhardt, Christian Diehl, Jens Gempt, Bernhard Meyer, Christoph Straube, Benedikt Wiestler, Jan J. Wilkens, Claus Zimmer, Stephanie E. Combs   +9 more
doaj   +1 more source

The experience of stereotactic radiosurgery and radiotherapy use in combined treatment of pituitary adenomas

Ukrainian Neurosurgical Journal, 2015
Introduction. Pituitary tumors take the third place in a structure of CNS neoplasms and ranged from 4 to 17% of all brain tumors.The purpose.
Andrey Gryazov, Olga Chuvashova, Nikolay Guk, Aleksandr Guk, Yuliya Medvedovskaya, Elena Andriychenko, Vitaliy Zakordonets   +6 more
doaj   +1 more source

Modeling dose to normal brain following hypofractionated stereotactic radiotherapy to a single brain metastasis. [PDF]

J Appl Clin Med Phys
Abstract Background Brain metastases (BM) occur in at least 20% of people with an advanced solid malignancy and can lead to morbidity or mortality if not controlled. Hypofractionated stereotactic radiotherapy (HF‐SRT) may be preferred to single fraction stereotactic radiosurgery (SRS) in certain clinical situations to improve the therapeutic ratio ...
Johns E, Hargrave C, Nissen L, Barry TJ, Bernard A, Pinkham MB.   +5 more
europepmc   +2 more sources

Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis

Tumor Biology, 2017
Whole brain radiotherapy has been a standard treatment of brain metastases. Stereotactic radiosurgery provides more focal and aggressive radiation and normal tissue sparing but worse local and distant control.
Muhammad Khan, Jie Lin, Guixiang Liao, Rong Li, Baiyao Wang, Guozhu Xie, Jieling Zheng, Yawei Yuan   +7 more
doaj   +1 more source

Stereotactic Ablative Body Radiotherapy (SABR) in The Management Spinal Metastases: A Brief Overview*

Indonesian Journal of Cancer, 2017
It is well known that radiotherapy provides successful pain relief in bone metastases. Advancements in imaging and radiotherapy delivery technology have enabled safe delivery of higher dose radiotherapy, which will produce more durable tumor control ...
HENRY KODRAT, SOEHARTATI GONDHOWIARDJO
doaj   +1 more source

LINAC stereotactic radiosurgery for trigeminal neuralgia –retrospective two-institutional examination of treatment outcomes

Radiation Oncology, 2018
Background In this pooled 2-center series LINAC radiosurgery (SRS) has been applied as a treatment option for a subset of refractory trigeminal neuralgia (TN) patients.
Ali Rashid, Bogdan Pintea, Thomas M. Kinfe, Gunnar Surber, Klaus Hamm, Jan P. Boström   +5 more
doaj   +1 more source

Optic-guided stereotactic radiotherapy

Medical Dosimetry, 1998
Stereotactic localization provides a powerful referencing system for radiation planning and treatment delivery. Although the standard approach of applying a rigid reference frame has been accepted for single-fraction therapy, a new, noninvasive approach is needed for fractionated therapy.
Departments of Radiation Oncology, Gainesville, FL, USA ( host institution ), Bova, Francis J ( author ), Meeks, Sanford L ( author ), Friedman, William A ( author ), Buatti, John M ( author )   +4 more
openaire   +3 more sources

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

Frontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani, Giovanni eAguzzi, David eSchaal, Pantaleo eRomanelli   +3 more
doaj   +1 more source